425: Kimberly-Clark to Acquire Kenvue in $48.7B Deal

Kimberly-Clark announces its intent to acquire Kenvue, creating a $32 billion global health and wellness leader with significant synergies and growth potential.

Summary

• Kimberly-Clark (K-C) will acquire Kenvue, forming a $32 billion global health and wellness leader.
• The transaction has an enterprise value of approximately $48.7 billion.
• The headline multiple for the acquisition is 14.3x Kenvue's LTM Adjusted EBITDA as of Q3 2025, with an effective multiple of 8.8x post-synergies.
• Pro forma shareholder ownership will be approximately 54% for Kimberly-Clark shareholders and 46% for Kenvue shareholders on a fully diluted basis.
• The acquisition is expected to be approximately $2.1 billion Adjusted EPS accretive to Kimberly-Clark by year two.
• Total anticipated run-rate synergies are estimated at approximately $2.1 billion, comprising $1.9 billion in cost synergies and $500 million in incremental profit from revenue synergies, partially offset by $300 million in reinvestment.
• The combined company is committed to maintaining a robust credit profile consistent with its current rating.
• The transaction is expected to close in the second half of 2026, subject to shareholder and regulatory approvals.

Sentiment

Score: 9

Explanation: The filing presents a highly optimistic view of the acquisition, emphasizing significant financial and strategic benefits, including substantial synergies, EPS accretion, and the creation of a market-leading entity with strong growth prospects.

Positives

• Creates a $32 billion global health and wellness leader with a powerful combined portfolio of 10 brands generating over $1 billion each.
• Positions the combined entity for higher growth, higher margins, and lower volatility.
• Anticipates top-tier adjusted operating profit percentage and double-digit total shareholder return.
• Projects organic growth ahead of weighted average category growth and top-tier adjusted constant currency EPS growth.
• Expected to be approximately $2.1 billion Adjusted EPS accretive to Kimberly-Clark by year two.
• Forecasts total anticipated run-rate synergies of approximately $2.1 billion, including significant cost and revenue synergies.
• The acquisition is seen as a powerful next step in Kimberly-Clark's transformation to higher-growth, higher-margin businesses.
• Offers tremendous complementarity across categories and geographies, accelerating growth in key markets.

Risks

• Conditions to the completion of the proposed transaction, including stockholder and regulatory approvals, may not be satisfied in a timely manner or at all.
• Competing offers or transaction proposals may be made, potentially disrupting the current agreement.
• Risks exist regarding the successful integration of the Kimberly-Clark and Kenvue businesses.
• The anticipated benefits and synergies of the proposed transaction may not be realized when expected or at all.
• The proposed transaction may not be completed in a timely manner or at all.
• Unexpected costs or expenses may arise from the proposed transaction.
• Risk of litigation related to the proposed transaction, which could result in expense or delay.
• Disruption to ongoing business operations and diversion of management's time may occur as a result of the transaction.
• The proposed transaction may adversely affect the ability to retain key personnel, customers, and suppliers.
• The credit ratings of the combined company could decline following the proposed transaction.
• The announcement or consummation of the proposed transaction may negatively affect the market price of the capital stock of Kimberly-Clark and Kenvue or their operating results.
• General risks include product liability litigation, product efficacy or safety concerns, inflation, interest rate and currency exchange rate fluctuations, government trade actions, natural disasters, acts of war, pandemics, raw material prices, manufacturing difficulties, supply chain disruptions, and disruptions in capital and credit markets.

Future Outlook

Kimberly-Clark expects the transaction to be approximately $2.1 billion Adjusted EPS accretive by year two and anticipates total run-rate synergies of approximately $2.1 billion. The combined entity is positioned for higher growth, higher margins, and lower volatility, with organic growth projected to be ahead of weighted average category growth and top-tier adjusted constant currency EPS growth. The transaction is expected to close in the second half of 2026.

Management Comments

• Mike Hsu (Kimberly-Clark Chairman and CEO): "With a shared commitment to developing science and technology to provide extraordinary care, we will serve billions of consumers across every stage of life. Over the last several years, Kimberly-Clark has undertaken a significant transformation to pivot our portfolio to higher-growth, higher-margin businesses while rewiring our organization to work smarter and faster. We have built the foundation and this transaction is a powerful next step in our journey. We look forward to working with the Kenvue team to bring these companies together, and are confident that we will drive significant value for our combined shareholders."
• Kirk Perry (Kenvue CEO): "Our combination with Kimberly-Clark unites two highly complementary portfolios filled with iconic, beloved brands and everyday essentials that people trust and count on throughout their lives. Together, our combined strengths, expanded capabilities and resources, and broader reach will empower us to innovate even faster and strengthen our category leadership. We truly believe this transaction with Kimberly-Clark will bring greater value to our shareholders, create new and different potential growth opportunities for our talented employees and deliver even more benefits to our customers and consumers."

Industry Context

This acquisition represents a significant consolidation within the global health and wellness and consumer goods sectors. By combining two portfolios of iconic brands, Kimberly-Clark aims to achieve greater scale, diversify its product offerings, and enhance its market leadership. This move aligns with broader industry trends where companies seek to optimize their portfolios for higher growth and margins, leverage synergies, and strengthen their competitive position in a dynamic consumer landscape.

Comparison to Industry Standards

• The combined company is positioned to achieve "top-tier adjusted operating profit %" and "double-digit total shareholder return," indicating an aim to exceed typical industry performance.
• Projections include "organic growth ahead of weighted average category growth" and "top-tier adjusted constant currency EPS growth," suggesting an ambition to outperform sector averages.
• The combined portfolio will boast 10 brands generating over $1 billion in annual sales, signifying a strong market presence and brand equity relative to many competitors in the consumer health and wellness industry.
• Specific comparable companies, projects, or detailed industry benchmarks are not explicitly named in this communication.

Legal Proceedings

• There is a risk of litigation related to the proposed transaction, including resulting expense or delay.

Stakeholder Impact

• Shareholders of both Kimberly-Clark and Kenvue are expected to benefit from significant value creation, double-digit total shareholder return, and EPS accretion for Kimberly-Clark shareholders.
• Kenvue employees may gain new and different potential growth opportunities within the combined organization.
• Customers and consumers are expected to receive even more benefits, with the combined entity serving billions across all stages of life and strengthening category leadership through faster innovation.
• There is a risk of adverse effects on the ability to retain key suppliers.
• Creditors are assured of a commitment to maintaining a robust credit profile, though there is a risk of credit ratings decline.

Next Steps

• Kimberly-Clark and Kenvue intend to file relevant materials with the SEC, including a Kimberly-Clark registration statement on Form S-4 that will include a joint proxy statement/prospectus.
• A definitive joint proxy statement/prospectus will be mailed to stockholders of Kimberly-Clark and Kenvue seeking their approval of their respective transaction-related proposals.
• The transaction requires Kenvue and Kimberly-Clark shareholder approvals, regulatory approvals, and satisfaction of other customary closing conditions.
• The transaction is expected to close in the second half of 2026.

Key Dates

Recommendation

The proposed acquisition is presented as a highly strategic and financially compelling move, creating a $32 billion global leader with substantial synergies ($2.1 billion run-rate) and significant EPS accretion for Kimberly-Clark by year two. The combined entity is projected to achieve higher growth, margins, and lower volatility, along with top-tier shareholder returns. This transformative transaction is expected to unlock considerable value for shareholders, making it a strong investment opportunity.

Keywords

Kimberly-Clark, Kenvue, Acquisition, Merger, Health and Wellness, Consumer Goods, FMCG, Synergies, EPS Accretion, Shareholder Value, Brands, Global Market